Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ajanta Pharma Ltd. Call Transcript 2026

Apr 21, 2026

59171_rns_2026-04-21_6a330df7-61cd-41b0-97b5-9fb5976fead0.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E [email protected] Mumbai 400 093, India W www.ajantapharma.com

==> picture [206 x 26] intentionally omitted <==

==> picture [70 x 74] intentionally omitted <==

21[st] April 2026

BSE Limited National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, Dalal Street, G block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ

Sub: Earnings Conference Call

Dear Sir / Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 5[th] May 2026, post Board meeting.

This is for your information and records please.

Yours Faithfully,

GAURANG Digitally signed by GAURANG CHINUBH CHINUBHAI SHAH AI SHAH Date: 2026.04.21 16:07:55 +05'30'

Gaurang Shah

Sr. VP – Legal & Company Secretary

Encl.: a/a

Corporate Identity Number - L24230MH1979PLC022059

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E [email protected] Mumbai 400 093, India W www.ajantapharma.com

==> picture [206 x 26] intentionally omitted <==

==> picture [70 x 74] intentionally omitted <==

Announcement

Ajanta Pharma to release Q4 FY 2026 Audited Financial Results on 5[th] May, 2026

16:30 hrs. – EARNINGS CONFERENCE CALL

The Company will host an Earnings Conference Call at 16:30 hrs. IST (19:00 hrs. SST/HKT, 12:00 hrs. BST, 07:00 hrs. US ET), during which the leadership team will discuss the financial performance and take questions. A transcript of the conference call will be available at www.ajantapharma.com.

Earnings Conference Call Dial-in Information

Date and Time May 5, 2026 at
16:30 – 17:30 hrs IST
19:00 – 20:00 hrs SST/HKT
12:00 – 13:00 hrs BST
07:00 – 08:00 hrs US ET
Dial-in Numbers
Diamondpass link for faster access Click here to register
Universal Access Primary Access:(+91 22 6280 1542)
(+91 22 7115 8372)
International Toll Free USA:18667462133
UK:08081011573
Hong Kong:800964448
Singapore:8001012045

For convenience and faster connectivity to the conference, kindly follow the below steps:

  1. Register through the Diamond pass link.

  2. You will receive a calendar invite along with a passcode and a PIN number. The passcode and PIN will be activated 30 minutes prior to the conference scheduled time.

  3. Dial the ‘conference Dial-in number’ you will receive on your email.

  4. On system prompt dial the PASSCODE followed by # key.

  5. On system prompt enter the PIN followed by # key.

6. If the line gets disconnected, you need to dial the ‘conference dial-in number’ again and follow the necessary steps.

Playback of Earnings Conference Call audio:

Playback of the earnings call will be available 120 minutes after the end of the call on our website (www.ajantapharma.com).

Contact:

Investor Relations

Rajeev Agarwal Abhineet Kumar E-Mail: [email protected] E-Mail: [email protected]

Corporate Identity Number - L24230MH1979PLC022059